Abstract |
The role of nitric oxide (NO) in migraine has been studied in the experimental glyceryl trinitrate (GTN)-infusion headache model. We hypothesized that GTN-induced headache may activate the trigeminovascular system and be associated with increased levels of sensory neuropeptides, including calcitonin gene-related peptide (CGRP). CGRP, vasoactive intestinal peptide (VIP), neuropeptide Y (NPY) and somatostatin plasma levels were measured before and after placebo/ sumatriptan injection and during GTN-induced headache. Following a double-blind randomized cross-over design, 10 healthy volunteers received subcutaneous sumatriptan 6 mg or placebo. This was succeeded by 20 min of GTN (0.12 µg kg(-1) min(-1)) infusion. At baseline no subject reported headache (using verbal rating scale from 0 to 10) and the jugular CGRP-like immunoreactivity (-LI) level was 18.6 ± 2.5 pmol/l. After a 20-min intravenous infusion of GTN 0.12 µg kg(-1) min(-1), median peak headache intensity was 4 (range 2-6) (P < 0.05), while jugular CGRP-LI levels were unchanged (19.0 ± 2.8 pmol/l; P > 0.05). There were no changes in VIP-, NPY- or somatostatin-LI. In conclusion, the NO donor GTN appears not to induce headache via immediate CGRP release.
|
Authors | C Kruuse, H K Iversen, I Jansen-Olesen, L Edvinsson, J Olesen |
Journal | Cephalalgia : an international journal of headache
(Cephalalgia)
Vol. 30
Issue 4
Pg. 467-74
(Apr 2010)
ISSN: 1468-2982 [Electronic] England |
PMID | 19673898
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Neuropeptide Y
- Nitric Oxide Donors
- Vasoconstrictor Agents
- Nitric Oxide
- Vasoactive Intestinal Peptide
- Somatostatin
- Sumatriptan
- Nitroglycerin
- Calcitonin Gene-Related Peptide
|
Topics |
- Adult
- Calcitonin Gene-Related Peptide
(blood)
- Cross-Over Studies
- Female
- Headache
(chemically induced, drug therapy, metabolism)
- Humans
- Male
- Neuropeptide Y
(blood)
- Nitric Oxide
(blood)
- Nitric Oxide Donors
(adverse effects)
- Nitroglycerin
(adverse effects)
- Reference Values
- Somatostatin
(blood)
- Sumatriptan
(administration & dosage)
- Vasoactive Intestinal Peptide
(blood)
- Vasoconstrictor Agents
(administration & dosage)
|